FIIs increase stake in Lupin in Q4FY15

10 Apr 2015 Evaluate

Foreign institutional investors (FIIs) have increased shareholding in Lupin to 34.69% at the end of March 2015 quarter from 31.77% in December 31, 2014. On the other hand, domestic institutional investors (DIIs) have reduced shareholding in the company to 8.67% at the end of March 2015 quarter from 10.73% as on December 31, 2014. Meanwhile, Non Institutions were holding 10.01 percent stake at the end of March 2015 quarter, down 83 basis points from 10.84 percent as on December 31, 2014.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×